China, Oct. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Uterine Artery Chemoimmunoembolization Combined with Radiotherapy in Locally Advanced Cervical Cancer(CIETAI-LACC): A Phase II Single-Arm Trial'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134606
Registration Time: 2026/10/16
Type: Interventional study
Primary Sponsor: Chongqing Qianjiang Central Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=323489
Published by HT Digital Content Services with permission from Health Daily Digest....